JP2022548221A5 - - Google Patents

Info

Publication number
JP2022548221A5
JP2022548221A5 JP2022515794A JP2022515794A JP2022548221A5 JP 2022548221 A5 JP2022548221 A5 JP 2022548221A5 JP 2022515794 A JP2022515794 A JP 2022515794A JP 2022515794 A JP2022515794 A JP 2022515794A JP 2022548221 A5 JP2022548221 A5 JP 2022548221A5
Authority
JP
Japan
Prior art keywords
amount
eye drop
castor oil
drop composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022515794A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022548221A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2020/011977 external-priority patent/WO2021049825A1/ko
Publication of JP2022548221A publication Critical patent/JP2022548221A/ja
Publication of JP2022548221A5 publication Critical patent/JP2022548221A5/ja
Pending legal-status Critical Current

Links

JP2022515794A 2019-09-09 2020-09-04 シクロスポリンおよびメントール含有ナノエマルジョン点眼組成物およびその製造方法 Pending JP2022548221A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20190111776 2019-09-09
KR10-2019-0111776 2019-09-09
PCT/KR2020/011977 WO2021049825A1 (ko) 2019-09-09 2020-09-04 사이클로스포린 및 멘톨 함유 나노 에멀젼 점안 조성물 및 그의 제조 방법

Publications (2)

Publication Number Publication Date
JP2022548221A JP2022548221A (ja) 2022-11-17
JP2022548221A5 true JP2022548221A5 (OSRAM) 2023-09-12

Family

ID=74867274

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022515794A Pending JP2022548221A (ja) 2019-09-09 2020-09-04 シクロスポリンおよびメントール含有ナノエマルジョン点眼組成物およびその製造方法

Country Status (8)

Country Link
US (1) US12576126B2 (OSRAM)
EP (1) EP4029493A4 (OSRAM)
JP (1) JP2022548221A (OSRAM)
KR (2) KR102273481B1 (OSRAM)
CN (1) CN114364372A (OSRAM)
CA (1) CA3149270A1 (OSRAM)
PH (1) PH12022550500A1 (OSRAM)
WO (1) WO2021049825A1 (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023190283A1 (ja) * 2022-03-28 2023-10-05 中外製薬株式会社 ポリオキシエチレン構造を含む油性成分を含有する化合物製剤
IL294896A (en) * 2022-07-20 2024-02-01 LYOTROPIC DELIVERY SYSTEMS Ltd Topical administration of cyclosporine to the eye

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635796B2 (en) 1990-03-16 2003-10-21 Sevenson Environmental Services, Inc. Reduction of leachability and solubility of radionuclides and radioactive substances in contaminated soils and materials
KR0167613B1 (ko) 1994-12-28 1999-01-15 한스 루돌프 하우스, 니콜 케르커 사이클로스포린-함유 연질캅셀제 조성물
KR100336090B1 (ko) 1998-06-27 2002-05-27 윤승원 오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제
US8663692B1 (en) 1999-05-07 2014-03-04 Pharmasol Gmbh Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
CN101448259A (zh) 2001-06-27 2009-06-03 诺基亚西门子通信公司 用于无线通信网中承载授权的方法和系统
WO2003053472A1 (en) 2001-12-21 2003-07-03 Senju Pharmaceutical Co., Ltd. Eye drops
MXPA04009385A (es) 2002-03-26 2005-01-25 Teva Pharma Microparticulas de drogas.
CN1232539C (zh) * 2002-05-10 2005-12-21 刘云清 有机药物与倍他环糊精衍生物的配合物及其制备方法
JP2006524190A (ja) * 2003-02-20 2006-10-26 テバ ファーマシューティカル インダストリーズ リミティド 薬剤のメントール溶液
US20070008894A1 (en) 2004-10-19 2007-01-11 Idt Corporation Telecommunications-based link monitoring system
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
KR100669510B1 (ko) 2005-08-17 2007-01-16 보람제약주식회사 사이크로스포린을 함유한 나노 에멀젼 농축액 조성물 및 그제조방법
CN101244256A (zh) * 2007-02-16 2008-08-20 中国科学院上海药物研究所 一种环孢菌素a眼用微/亚微乳原位凝胶制剂及其制备方法
EP2575854B1 (en) * 2010-05-25 2016-03-09 Allergan, Inc. Cyclosporin emulsions
WO2012015211A2 (ko) 2010-07-30 2012-02-02 주식회사종근당 사이클로스포린 에이 함유 점안제 조성물
WO2012074588A2 (en) 2010-08-30 2012-06-07 President And Fellows Of Harvard College Shear controlled release for stenotic lesions and thrombolytic therapies
US8455991B2 (en) 2010-09-24 2013-06-04 Stats Chippac Ltd. Integrated circuit packaging system with warpage control and method of manufacture thereof
US20140302146A1 (en) 2011-07-08 2014-10-09 Rohto Pharmaceutical Co.,Ltd. Ophthalmic Aqueous Composition
KR101211902B1 (ko) 2012-04-30 2012-12-13 주식회사 휴온스 사이클로스포린 함유 무자극성 나노에멀젼 안약 조성물
KR101492447B1 (ko) 2013-05-20 2015-02-23 주식회사태준제약 사이클로스포린을 함유하는 나노에멀젼 점안 조성물 및 그의 제조 방법
US10963928B2 (en) 2014-08-21 2021-03-30 Stubhub, Inc. Crowdsourcing seat quality in a venue
ES2630106T3 (es) 2014-10-07 2017-08-18 Cyprumed Gmbh Formulaciones farmacéuticas para la administración oral de fármacos peptídicos o proteicos
KR20170032808A (ko) * 2015-09-15 2017-03-23 주식회사 엘지생활건강 멘톨 또는 멘톨 유도체를 포함하는 용해성 미세바늘 패치
CN105726479B (zh) 2016-03-24 2018-06-22 北京茗泽中和药物研究有限公司 环孢素眼用乳剂
US11583496B2 (en) 2016-10-12 2023-02-21 PS Therapy Inc. Drug vehicle compositions and methods of use thereof
CA3039464C (en) * 2016-10-12 2026-02-17 Ps Therapy, Inc. Artificial tear, contact lens and drug vehicle compositions and methods of use thereof
KR102665630B1 (ko) 2017-12-07 2024-05-14 라이온 가부시키가이샤 수성 안과용 조성물 및 에멀션 입자의 미립화 방법
CN110090294A (zh) 2019-04-09 2019-08-06 嘉兴市爵拓科技有限公司 具有改善的干燥保护和保留的眼用组合物

Similar Documents

Publication Publication Date Title
CN101217947B (zh) 包含壳聚糖和环糊精的纳米颗粒
US6649192B2 (en) Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms
CN114269816B (zh) 多孔纤维素微粒及其制备方法
Masalova et al. Alginate and chitosan gel nanoparticles for efficient protein entrapment
AU757786B2 (en) Formulations of fexofenadine
JP5203355B2 (ja) 懸濁性ハイドロゲルとその製造方法
JP2006504636A5 (OSRAM)
TW201023912A (en) Pharmaceutical suspension
JP2022519580A (ja) 複合体化剤を含む眼科用製剤から防腐剤を除去するためのシステムおよび方法
JP6845915B2 (ja) 注射のためのテコビリマットの医薬組成物およびその調製方法
CN102921013A (zh) 具有孔隙结构的壳聚糖纳米粒的制备方法及应用
CN102188372A (zh) 一种药物透明纳米分散体及其制备方法
Al-Roujayee et al. Alginate-based systems: advancements in drug delivery and wound healing
CN104902873A (zh) 溶解性差的活性成分的薄膜剂形式的口服和/或含服组合物、其制备方法以及其用途
CN114366816A (zh) 一种具有优良冻干再分散性的壳聚糖纳米粒、冻干制剂及其制备方法和应用
CN104921964A (zh) 具有抗氧化性的卡拉胶-茶多酚微球及制备方法和用途
KR102638866B1 (ko) 사이클로스포린 및 멘톨 함유 나노 에멀젼 점안 조성물 및 그의 제조 방법
IL274149B1 (en) Extended release formulations for intra-articular applications
CN117358165B (zh) 一种核壳结构柑橘精油纳米混悬剂凝胶的制备工艺
CA2578325A1 (en) Megestrol acetate suspension
Suares et al. Cellulose-Based Drug Delivery Systems in Lung Disorders
Rodríguez et al. A novel method for the in vitro assembly of virus-like particles and multimeric proteins
JP2016034931A (ja) 外用剤組成物
JP2018140955A (ja) 加工増粘多糖類
EP2266596B1 (en) Pharmaceutical composition and a method for the production thereof